Kelly K. Hunt Stephan A. Vorburger Stephen G. Swisher
The possibility of treating cancer, a disease defined by genetic defects, by introducing genes targeting these very alterations has led to an immense interest in gene therapy for cancer. Although incremental successes have been realized, enthusiasm for gene therapy has declined due to an increasing number of obstacles. These obstacles include vector systems that do not reach systemic metastases, therapeutic genes with redundant mec- nisms allowing for cellular resistance, and toxicities in clinical trials leading to premature closure of these studies. Different tactics to overcome or...
The possibility of treating cancer, a disease defined by genetic defects, by introducing genes targeting these very alterations has led to an immense ...
Kelly K. Hunt Stephan A. Vorburger Stephen G. Swisher
The possibility of treating cancer, a disease defined by genetic defects, by introducing genes targeting these very alterations has led to an immense interest in gene therapy for cancer. Although incremental successes have been realized, enthusiasm for gene therapy has declined due to an increasing number of obstacles. These obstacles include vector systems that do not reach systemic metastases, therapeutic genes with redundant mec- nisms allowing for cellular resistance, and toxicities in clinical trials leading to premature closure of these studies. Different tactics to overcome or...
The possibility of treating cancer, a disease defined by genetic defects, by introducing genes targeting these very alterations has led to an immense ...
